Allan Reine - Net Worth and Insider Trading
Allan Reine Net Worth
The estimated net worth of Allan Reine is at least $13,089 dollars as of 2024-11-12. Allan Reine is the See Remarks of Pieris Pharmaceuticals Inc and owns about 813 shares of Pieris Pharmaceuticals Inc (PIRS) stock worth over $13,089. Details can be seen in Allan Reine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Allan Reine has not made any transactions after 2017-08-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Allan Reine
Allan Reine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Allan Reine owns 2 companies in total, including Foghorn Therapeutics Inc (FHTX) , and Pieris Pharmaceuticals Inc (PIRS) .
Click here to see the complete history of Allan Reine’s form 4 insider trades.
Insider Ownership Summary of Allan Reine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2020-10-22 | Chief Financial Officer |
| PIRS | Pieris Pharmaceuticals Inc | 2017-08-17 | See Remarks |
Allan Reine Latest Holdings Summary
Allan Reine currently owns a total of 1 stock. Allan Reine owns 813 shares of Pieris Pharmaceuticals Inc (PIRS) as of August 17, 2017, with a value of $13,089.
Latest Holdings of Allan Reine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2017-08-17 | 813 | 16.10 | 13,089 |
Holding Weightings of Allan Reine
Allan Reine Form 4 Trading Tracker
According to the SEC Form 4 filings, Allan Reine has made a total of 0 transactions in Pieris Pharmaceuticals Inc (PIRS) over the past 5 years. The most-recent trade in Pieris Pharmaceuticals Inc is the acquisition of 813 shares on August 17, 2017, which cost Allan Reine around $313,300.
Insider Trading History of Allan Reine
- 1
Allan Reine Trading Performance
GuruFocus tracks the stock performance after each of Allan Reine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Allan Reine is 31.53%. GuruFocus also compares Allan Reine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Allan Reine within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Allan Reine's insider trading performs compared to the benchmark.
Performance of Allan Reine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.41 | | | | | |
| Relative Return to S&P 500(%) | 13.52 | | | | | |
Allan Reine Ownership Network
Ownership Network List of Allan Reine
Ownership Network Relation of Allan Reine
Allan Reine Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Allan Reine is the Chief Financial Officer of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Allan Reine made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 58,859 shares made by Carlos Costa , a net sale of 311,297 shares made by Samuel Agresta , and a net sale of 20,000 shares made by Steven F. Bellon .
In summary, during the past 3 months, insiders sold 78,859 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 78,859 shares. During the past 18 months, 401,156 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 401,156 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Allan Reine Mailing Address
Above is the net worth, insider trading, and ownership report for Allan Reine. You might contact Allan Reine via mailing address: C/o Pieris Pharmaceuticals, Inc., 255 State Street, Boston Ma 02109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
